Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New collaborations offer hope for HIV/AIDS vaccine

22.02.2005


Prospects for a safe, effective AIDS vaccine are improving as researchers from the public and private sectors begin to collaborate in new and creative ways, researchers said today at the 2005 Annual Meeting of the American Association for the Advancement of Science (AAAS).



According to the Joint United Nations Programme on AIDS (UNAIDS) approximately 39 million people are living with HIV, and an estimated 4.9 million people were newly infected with HIV in 2004 alone.

New vaccines take decades to create, and the process can be slowed down when researchers work independently. Another reason that we don’t have an AIDS vaccine yet is that making drugs for patients already infected with the virus has generally taken top priority. "Given the magnitude of the AIDS epidemic and the complexity of the virus, the world must continue to galvanize resources to develop new prevention technologies, most importantly a vaccine," said Seth Berkley, president of the International AIDS Vaccine Initiative. "An effective AIDS vaccine is our best hope to stop the spread of HIV." Anthony S. Fauci M.D., director of the National Institute of Allergy and Infectious Diseases, said that for the National Institutes of Health, the new paradigm requires expanding beyond basic research. It involves a new focus on product development through alliances with the pharmaceutical industry and other research agencies.


"At NIH we are attempting to we strike a balance between the time-honored goals of pursuing basic scientific research as the true foundation of all our objectives, and the need for applied research, and novel research partnerships, to rapidly develop vaccines, therapies and other interventions," he said

Differences in study design and research methods can make it difficult to get the most out of vaccine trials as they are currently done, Fauci said. The leveling-off of NIH’s research budget has added to the need for greater coordination and data-sharing among studies, so that results from a clinical trial conducted in one country could, for example, be better applied in another country. To that end, Fauci said, NIH and other agencies are also coordinating research protocols, standards and measures. "Our new role is not just doing basic research but also getting important countermeasures to the public." "Partnerships between governments, industry and multilateral organizations can make a substantial difference in advancing AIDS vaccine research and development," said Berkley. "A model effort is the partnership across Asia, Europe and the United States in conducting India’s first-ever human clinical trial of a vaccine."

New types of collaborations for global health are catching on outside of AIDS vaccine research as well. The journal Science, published by AAAS, recently listed the growth of public-private partnerships for AIDS and other public health research as one of the top ten research advances for 2004, saying that "A revolution in public health is fundamentally shifting the way medicines are developed and delivered to the world’s poorest people." (Science, 17 December 2004)

Ginger Pinholster | EurekAlert!
Further information:
http://www.aaas.org

More articles from Health and Medicine:

nachricht TSRI researchers develop new method to 'fingerprint' HIV
29.03.2017 | Scripps Research Institute

nachricht Periodic ventilation keeps more pollen out than tilted-open windows
29.03.2017 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Researchers shoot for success with simulations of laser pulse-material interactions

29.03.2017 | Materials Sciences

Igniting a solar flare in the corona with lower-atmosphere kindling

29.03.2017 | Physics and Astronomy

As sea level rises, much of Honolulu and Waikiki vulnerable to groundwater inundation

29.03.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>